These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 39029635)

  • 1. 3D printed benznidazole tablets based on an interpolyelectrolyte complex by melting solidification printing process (MESO-PP): An innovative strategy for personalized treatment of Chagas disease.
    Magi MS; Lopez-Vidal L; Rega P; Ibarra M; Palma SD; Jimenez Kairuz A; Real JP
    Int J Pharm; 2024 Sep; 662():124476. PubMed ID: 39029635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-kinetic release of benznidazole-loaded multiparticulate drug delivery systems based on polymethacrylate interpolyelectrolyte complexes.
    García MC; Martinelli M; Ponce NE; Sanmarco LM; Aoki MP; Manzo RH; Jimenez-Kairuz AF
    Eur J Pharm Sci; 2018 Jul; 120():107-122. PubMed ID: 29705213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benznidazole in vitro dissolution release from a pH-sensitive drug delivery system using Zif-8 as a carrier.
    de Moura Ferraz LR; Tabosa AÉGA; da Silva Nascimento DDS; Ferreira AS; Silva JYR; Junior SA; Rolim LA; Rolim-Neto PJ
    J Mater Sci Mater Med; 2021 May; 32(6):59. PubMed ID: 33999312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions.
    Figueirêdo CBM; Nadvorny D; Vieira ACQM; Schver GCRM; Soares Sobrinho JL; Rolim Neto PJ; Lee PI; Soares MFR
    Eur J Pharm Sci; 2018 Jul; 119():208-218. PubMed ID: 29679707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benznidazole microcrystal preparation by solvent change precipitation and in vivo evaluation in the treatment of Chagas disease.
    Maximiano FP; de Paula LM; Figueiredo VP; de Andrade IM; Talvani A; Sá-Barreto LC; Bahia MT; Cunha-Filho MS
    Eur J Pharm Biopharm; 2011 Aug; 78(3):377-84. PubMed ID: 21397015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel solid dispersions of benznidazole: preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system.
    Fonseca-Berzal C; Palmeiro-Roldán R; Escario JA; Torrado S; Arán VJ; Torrado-Santiago S; Gómez-Barrio A
    Exp Parasitol; 2015 Feb; 149():84-91. PubMed ID: 25583295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organic solvent-free benznidazole nanosuspension as an approach to a novel pediatric formulation for Chagas disease.
    Magi MS; Lopez-Vidal L; García MC; Stempin CC; Marin C; Maletto B; Palma SD; Real JP; Jimenez-Kairuz AF
    Ther Deliv; 2024; 15(9):699-716. PubMed ID: 39101355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technological innovation strategies for the specific treatment of Chagas disease based on Benznidazole.
    Ferraz LRM; Alves AÉG; Nascimento DDSDS; Amariz IAE; Ferreira AS; Costa SPM; Rolim LA; Lima ÁAN; Rolim Neto PJ
    Acta Trop; 2018 Sep; 185():127-132. PubMed ID: 29452113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel benznidazole formulations: physicochemical characterization and in vivo evaluation on parasitemia reduction in Chagas disease.
    Palmeiro-Roldán R; Fonseca-Berzal C; Gómez-Barrio A; Arán VJ; Escario JA; Torrado-Durán S; Torrado-Santiago S
    Int J Pharm; 2014 Sep; 472(1-2):110-7. PubMed ID: 24928135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of novel oral ricobendazole formulation applying melting solidification printing process (MESO-PP): An innovative solvent-free alternative method for 3D printing using a simplified concept and low temperature.
    Real JP; Barberis ME; Camacho NM; Sánchez Bruni S; Palma SD
    Int J Pharm; 2020 Sep; 587():119653. PubMed ID: 32682957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polysaccharides-based multiparticulated interpolyelectrolyte complexes for controlled benznidazole release.
    García MC; Manzo RH; Jimenez-Kairuz A
    Int J Pharm; 2018 Jul; 545(1-2):366-377. PubMed ID: 29747000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole.
    Fernández ML; Marson ME; Ramirez JC; Mastrantonio G; Schijman AG; Altcheh J; Riarte AR; Bournissen FG
    Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):218-21. PubMed ID: 26982179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amorphous solid dispersion of a binary formulation with felodipine and HPMC for 3D printed floating tablets.
    Mora-Castaño G; Millán-Jiménez M; Niederquell A; Schönenberger M; Shojaie F; Kuentz M; Caraballo I
    Int J Pharm; 2024 Jun; 658():124215. PubMed ID: 38740104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extemporaneous benznidazole oral suspension prepared from commercially available tablets for treatment of Chagas disease in paediatric patients.
    García MC; Manzo RH; Jimenez-Kairuz AF
    Trop Med Int Health; 2015 Jul; 20(7):864-70. PubMed ID: 25784402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of novel formulations for Chagas' disease: Optimization of benznidazole chitosan microparticles based on artificial neural networks.
    Leonardi D; Salomón CJ; Lamas MC; Olivieri AC
    Int J Pharm; 2009 Feb; 367(1-2):140-7. PubMed ID: 18938233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of effervescent tablets containing benzonidazole complexed with cyclodextrin.
    Maximiano FP; Costa GH; de Sá Barreto LC; Bahia MT; Cunha-Filho MS
    J Pharm Pharmacol; 2011 Jun; 63(6):786-93. PubMed ID: 21585376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical pharmacokinetics of benznidazole-loaded interpolyelectrolyte complex-based delivery systems.
    García MC; Guzman ML; Himelfarb MA; Litterio NJ; Olivera ME; Jimenez-Kairuz A
    Eur J Pharm Sci; 2018 Sep; 122():281-291. PubMed ID: 30018011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous liposomal benznidazole as trypanocidal agent: increasing drug delivery to liver is not enough.
    Morilla MJ; Montanari JA; Prieto MJ; Lopez MO; Petray PB; Romero EL
    Int J Pharm; 2004 Jul; 278(2):311-8. PubMed ID: 15196636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.
    Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF
    J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic application of twin-screw granulation and selective laser sintering 3D printing for the development of pharmaceutical dosage forms with enhanced dissolution rates and physical properties.
    Thakkar R; Zhang Y; Zhang J; Maniruzzaman M
    Eur J Pharm Biopharm; 2021 Jun; 163():141-156. PubMed ID: 33838262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.